LOAN AGREEMENT Between Paseco ApS c/o Crowe Horwath Strandvejen 58 5

Exhibit 10.14

Between

Paseco ApS

x/x Xxxxx Xxxxxxx

Xxxxxxxxxxx 00 0

0000 Xxxxxxxx

CVR-nr: 31 36 36 08

And

Dandrit Biotech A/S

Symbian Sciencepark Xxxxxxxxxxxx 0

0000 Xxxxxxxxx 0

CVR-nr. 26027322

(Paseco ApS and Dandrit Biotech A/S are individually referred to as "Party" and jointly as the "Parties")

Whereas:

A. Dandrit Biotech A/S are in the process of raising new equity via a reverse merger into an USA company and subsequent listing in the US

B. Paseco ApS has agreed to issue certain loans to Dandrit Biotech A/S to ensure sufficient equity in Dandrit Biotech A/S during the process, and

C. Dandrit Biotech A/S has chosen to accept these loans

Now therefore, the parties have agreed as follows:

1. The loans

Paseco ApS has agreed to issue the following loans to Dandrit Biotech A/S.

DKK 2,500,000 issued as of February 15, 2014

DKK 2,300,000 issued as of March 18, 2014

2. Interest

The loans will accrue interest at 5% per year as from the time where they are received by Dandrit Biotech and until repayment is done.

3. Repayment

The loans are due 14 days after completion of the contemplated public offering in Dandrit Biotech USA, Inc. or February 1, 2015.

Dandrit Biotech is entitled to repay the loans at any time.

4. Other provisions

This Agreement supersedes all previous agreements, written or oral, between the Parties.

This Agreement is made in English and signed by the Parties in two copies, one copy for each Party.

DanDrit Biotech A/S
Date: March 7, 2014		Date: March 21, 2014
Signature:	/s/ Xxxx Xxxx Xxxxx Xxxxx	Signature:	/s/ Niels Xxxx Xxxxxxx
Xx. Xxxx Xxxx Xxxxx Xxxxx,		Mr. Niels Xxxx Xxxxxxx,
President and Chief Executive Officer		Chairman of the Board of Directors

Document Metadata